文献速递主动脉疾病

年轻患者肾下型与近肾型腹主动脉瘤的开放与腔内修复结局

Infrarenal and juxtarenal abdominal aortic aneurysm repair in young patients.
PubMed 文献 · J Vasc Surg · 2025-04-28

单中心回顾性研究纳入2010年1月至2021年12月连续230例70岁以下原发肾下型或近肾型腹主动脉瘤患者,比较开放手术与腔内修复(含开窗腔内修复)的结局。30天死亡率为0.9%,开放手术与腔内修复的重大非致死并发症分别为2.4%与3.4%,5年生存率与免于晚期再干预率分别为89%与88%,与修复方式或动脉瘤范围无关。

要点

  • 70岁以下肾下型或近肾型腹主动脉瘤患者择期开放手术或腔内修复的30天死亡率为0.9%。
  • 开放手术重大非致死并发症2.4%(2/83),腔内修复3.4%(5/147)。
  • 估计5年生存率89%±2%、免于晚期再干预率88%±2%,与修复方式或动脉瘤范围无关。

核心结论

  • 肾下型腔内修复、开窗腔内修复与开放手术治疗经过适当选择的年轻肾下型及近肾型腹主动脉瘤患者,早期与中期结局良好。

研究设计与样本

  • 单中心回顾性研究,纳入2010年1月至2021年12月连续230例70岁以下原发肾下型或近肾型腹主动脉瘤患者,其中肾下型133例(开放手术53例、腔内修复80例),近肾型97例(开放手术30例、开窗腔内修复67例)。
  • 主要终点为30天死亡率,次要终点为生存率与免于再干预率,数据以中位数(四分位距)表示,P<.05为显著。

主要发现

  • 30天死亡率为0.9%(n=2)。
  • 开放手术重大非致死并发症2.4%(2/83),腔内修复3.4%(5/147):心肌梗死(开放手术1例)、临时肾替代治疗(开放手术1例)、需延长通气的呼吸衰竭(腔内修复2例)、再手术(开放手术2例 vs 腔内修复3例)。
  • 重症监护与总住院时间中位数:开放手术分别为2天(四分位距1-2天)与6天(四分位距4-7天),腔内修复分别为1天(四分位距0-1天)与2天(四分位距1-3天)(P<.001)。
  • 中位随访90个月(四分位距59-121个月),估计5年生存率89%±2%、免于晚期再干预率88%±2%,与修复方式(P=.53)或动脉瘤范围(P=.25)无关。
  • 冠状动脉疾病在腔内修复患者中更常见(48% vs 开放手术23%,P<.001),在近肾型患者中也更常见(51% vs 肾下型31%,P=.003)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the outcome of elective open surgical repair (OSR) and endovascular repair (EVAR) of primary infrarenal (IR) and juxtarenal (JR) abdominal aortic aneurysms (AAA) in patients <70 years of age. METHODS: Single-center retrospective study of consecutive patients <70 years old with primary IRAAA and JRAAA treated by OSR and EVAR between January 2010 and December 2021. The primary end point was 30-day mortality. Secondary end points were survival and freedom from reintervention. Data are presented as median (interquartile range [IQR]). A P value of <.05 was considered significant. RESULTS: We included 230 patients (214 men; median age 65 years; range, 64-67 years) who underwent repair of IRAAA (n = 133; 53 OSR, 80 EVAR) and JRAAA (n = 97; 30 OSR, 67 fenestrated EVAR). Coronary artery disease was more prevalent in EVAR patients (48% vs OSR, 23%; P < .001) and those with JRAAA (51% vs IRAAA: 31%; P = .003). The 30-day mortality rate was 0.9% (n = 2). Major nonfatal complications occurred in 2.4% of patients (2/83) after OSR and 3.4% (5/147) after EVAR: myocardial infarction (n = 1; OSR), temporary renal replacement therapy (n = 1; OSR), respiratory failure requiring prolonged ventilation (n = 2; EVAR), and reoperation (n = 5; OSR 2 vs EVAR 3). The median critical care and total hospital stay was as follows: OSR 2 days (IQR, 1-2 days) and 6 days (IQR, 4-7 days); EVAR 1 day (IQR, 0-1 day) and 2 days (IQR, 1-3 days) (P < .001). The median follow-up was 90 months (IQR, 59-121 months). Estimated 5-year survival (± standard error) and freedom from late reintervention were 89% ± 2% and 88% ± 2%, respectively, with no difference related to modality of repair (P = .53) or aneurysm extent (P = .25). CONCLUSIONS: IR EVAR, fenestrated EVAR, and OSR are associated with excellent early and mid-term outcomes in appropriately selected younger patients with IR and JR AAA.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bertagna G, Juszczak M, Vezzosi M, et al. Infrarenal and juxtarenal abdominal aortic aneurysm repair in young patients. J Vasc Surg. 2025. PMID: 40306599. doi:10.1016/j.jvs.2025.04.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。